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Background: The role of infarct size on left ventricular (LV) remodeling in heart failure after an acute ST-segment
elevation myocardial infarction (STEMI) is well recognized. Infarct size, as determined by cardiovascular magnetic
resonance (CMR), decreases over time. The amount, rate, and duration of infarct healing are unknown.
Methods: A total of 66 patients were prospectively enrolled after reperfusion for an acute STEMI. Patients
underwent a CMR evaluation within 1 week, 4 months, and 14 months after STEMI.
Results: Mean infarct sizes for the 66 patients at baseline (acute necrosis), early follow-up (early scar), and late
follow-up (late scar) were 25 ± 17 g, 17 ± 12 g, and 15 ± 11 g, respectively. Patients were stratified in tertiles, based
on infarct size, with the largest infarcts having the greatest absolute decrease in mass at early and late scar. The
percent reduction of infarct mass was independent of initial infarct size. There was an 8 g or 32% decrease in
infarct mass between acute necrosis and early scar (p < 0.01) with a 2 g or 12% additional decrease in infarct mass
between early and late scar (p < 0.01).
Conclusions: Infarct healing is a continuous process after reperfusion for STEMI, with greatest reduction in infarct
size in the first few months. The dynamic nature of infarct healing through the first year after STEMI indicates that
decisions based on infarct size, and interventions to reduce infarct size, must take into consideration the time frame
of measurement.
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The role of left ventricular (LV) remodeling in the clin-
ical course of heart failure following an acute myocardial
infarction (MI) is well recognized [1-4]. It is known that
identification of previous MI, as determined by late
gadolinium enhancement (LGE) cardiovascular magnetic
resonance (CMR), has a significant impact on a patient’s
mortality [5,6]. We have previously shown that initial in-
farct size by LGE on CMR, measured within a few days
after reperfusion for ST-segment elevation MI (STEMI)
is associated with cardiac event-free survival [7]. Other
investigators have demonstrated that the area of LGE
decreases within the first few months of the acute event* Correspondence: ed-wu@northwestern.edu
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reproduction in any medium, provided the or[8-10]. This change was attributed to clearing of necrotic
myocardium, inflammatory cells, residual edema, and
hemorrhage and replacement by scar tissue.
It is unknown over what period of time infarct healing
occurs from acute necrosis to chronic scar, as well as
how the initial infarct size impacts the amount of healing
and the degree of LV remodeling. We hypothesized that
the majority of infarct healing occurs within 3–4 months of
MI but continues at a slower rate for up to a year.
Methods
We prospectively enrolled 66 patients admitted to the
coronary care unit at Northwestern Memorial Hospital
following an acute STEMI between March 1999 and July
2008. All patients underwent emergent percutaneous
coronary intervention (PCI) and were willing to have
CMR performed within 1 week and at approximately
4 months and 12 months after the event. Patients were
included if they fulfilled the criteria of documented acuteal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[2] at least 1.0 mm ST-segment elevation in two contigu-
ous leads and [3] elevated creatinine phosphokinase MB
(CPKMB) isoenzyme levels. We did not recruit patients
with a known history of previous acute MI, PCI, or cor-
onary artery bypass surgery. We also excluded patients
with frequent and recurrent ventricular arrhythmias, un-
stable hemodynamics requiring intravenous inotropic
agents, or contraindications to CMR such as pacemakers
or defibrillators. Before the first CMR study, all partici-
pants gave written informed consent to the study proto-
col, which was approved by the Institutional Review
Board at Northwestern University.
Cardiac magnetic resonance
CMR was performed in a 1.5 T clinical scanner (Siemens,
Erlangen, Germany). All images were acquired with a
body phased-array receiver coil during repeat breath-
holds and were electrocardiographically gated as previ-
ously described [11-14]. Functional assessment of the left
ventricle was performed without contrast using a cine
steady-state free precession (FISP) sequence. Sequential
short axis images were acquired every 10 mm with a
@6 mm slice thickness to cover the entire left ven-
tricle. LGE images were acquired at identical slice
positions as the cine images at least 10 minutes after
the administration of gadopentetate dimeglumine
(gadolinium-DTPA; Berlex, Montville, NJ, USA),
0.2 mmol/kg of body weight, using a T1-weighted,
inversion-recovery, fast gradient-echo pulse sequence
with inversion times set to null normal myocardium
[13]. Matrix size was 256, resulting in a typical voxel
size of 1.9 mm by 1.4 mm by 6.0 mm. All images
were acquired using the same technique and pulse
sequences to minimize variation in image quality
that could impact infarct size quantification.
Quantitative analysis of LV mass, end-diastolic vol-
ume, end-systolic volume, and ejection fraction (EF)
were performed by manually tracing the epicardial
border (excluding epicardial fat) and endocardial borders
(excluding papillary muscles) at end-diastole and end-
systole for each short-axis slice. Three-dimensional
volumes were calculated as the sum of [area * (slice
thickness + distance between slices)] of all short axis
slices. Volume indices were calculated by dividing the
end-diastolic volume (EDVI) or end-systolic volume
(ESVI) by the body surface area.
Acutely necrotic, early scar, and late scar tissue areas
were determined by manually planimetering the regions
of LGE (>2 standard deviations over remote signal inten-
sity) on each of the contrast-enhanced CMR tomograms
and summed, as previously described and performed by
our group. [11-13]. Areas of microvascular obstruction
(MVO) (dark areas of absent contrast surrounded byhyperenhanced infarct tissue on LGE images) were
included in the total infarct area [5,15]. The summed
area was multiplied by the specific gravity of myocar-
dium to obtain the infarct mass. Infarct size was the per-
cent of total LV mass that was infarct. In a subset of 56
studies including a mix of acute necrosis, early scar, and
late scar studies, interobserver reproducibility was per-
formed between two observers. The correlation coeffi-
cient for infarct size is 0.97 with a mean difference of
0.16% with a 95% confidence interval range from −3.6%
to 3.9%.
Statistical analysis
Results are expressed as mean ± standard deviation, un-
less otherwise noted. A paired t-test was used in the pri-
mary analysis to compare quantitative values between
two time points (acute necrosis to early scar and early
scar to late scar). Patients were further divided into ter-
tiles by infarct size (small, medium, and large infarcts)
for secondary analysis. Because of multiple comparisons,
a Bonferroni correction was performed to avoid false
positive findings. An alpha level of 0.05 was divided by
22 comparisons, and a two-tailed p-value of <0.002 was
considered statistically significant. Additional repeated
measure analysis of variance (ANOVA) analysis was per-
formed to investigate differences in infarct mass and in-
farct size between tertile groups, followed by post-hoc
testing with Bonferroni correction. Unpaired t-test and a
Fisher’s exact test were used to compare differences be-
tween groups of continuous and categorical variables, re-




The clinical and angiographic characteristics of the
patients are shown in Table 1. The majority were men
(91%) with MI involving the left anterior descending ar-
tery (56%). All subjects had successful reperfusion with
PCI within 24 hours of presentation to the hospital. The
patients were almost all discharged on appropriate med-
ical therapy after PCI: anti-platelet agent, beta blocker,
angiotensin converting enzyme inhibitor, and statin (see
Table 1). The use of aldosterone antagonists was not
collected.
Infarct healing
Patients had CMR at a mean of 3 ± 1.7 days (acute ne-
crosis), 4 ± 1.3 months (early scar), and 14 ± 3 months
(late scar) (see Table 2). Infarct area, expressed both in
infarct mass in absolute terms and as a percent of LV
mass, decreased between the acute necrosis and early
scar (25 ± 17 g vs 17 ± 12 g, p < 0.0001) and also between
early and late scar (15 ± 11 g, p < 0.0001), with the





Diabetes mellitus 12 (18%)
Hypertension 28 (42%)
Hypercholesterolemia 36 (55%)
Family History 22 (33%)
Tobacco Use 32 (48%)
Angiographic findings
Left anterior descending IRA 37 (56%)
Left circumflex IRA 7 (11%)
Right coronary IRA 22 (33%)
Medication use
IIB-IIIA inhibitor 64 (97%)
Antiplatelet (aspirin and/or clopidogrel) 64 (97%)
ß-Blocker 62 (94%)
ACE inhibitor 57 (86%)
Statin 62 (94%)
Data presented as mean±SD or numbers (%) of subjects. ACE, angiotensin
converting enzyme; CAD, coronary artery disease; IRA, infarct related artery;
TIMI, thrombolysis in myocardial infarction.
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necrosis and early scar (Figure 1). There were 9 patients
that had an increase in infarct size between early and
late scar, meaning that 86% of patients had ongoing in-
farct healing beyond early scar. EDVI did not signifi-
cantly change, but EF increased significantly between
acute necrosis and early scar; increases in EF thereafter
were not significant. LV mass decreased significantly be-
tween acute necrosis and early scar (from 115 ± 22 g to
103 ± 19 g, p < 0.0001). LV mass increased slightly, but
not by a statistically significant amount, between early
and late scar (from 103 ± 19 to 106 ± 22, p < 0.16). An in-
crease in total LV mass could artificially decrease the








CMR 1-2 CMR 2-3
Days after MI 3±1.7 125±40 436±93
Infarct Mass (g) 25±17 17±12 15±11 < 0.0001 < 0.0001
Infarct Size (%) 21±13 16±11 13±9.5 < 0.0001 < 0.0001
EF (%) 42±10 46±10 46±11 < 0.0001 0.74
EDV Index (ml/m2) 79±17 82±18 82±20 0.04 0.78
LV Mass (g) 115±22 103±19 106±22 < 0.0001 0.16
Data presented as mean ± SD. EDV, end-diastolic volume; EF, ejection fraction;
LV, left ventricular; MI, myocardial infarction. P-value < 0.002 statistically
significant with Bonferroni correction (22 comparisons).in infarct size, but there was no statistically significant
increase in total LV mass at either early or late scar.
There is no linear relationship or correlation between
changes in infarct mass and changes in LV mass.
When patients were subdivided into tertiles based on
size of acute necrosis (Figure 2), the reduction in infarct
size (both in terms of absolute mass and percent of LV
mass) decreased significantly in patients with small (<
15 g), medium (between 15 g and 30 g), and large (>
30 g) infarcts at early scar and decreased further at late
scar. The absolute reduction in infarct size was greatest
in patients with the largest infarcts at baseline, with a re-
duction in infarct mass of 17 ± 10 g from acute necrosis
to late scar, as compared to 3.5 ± 3.7 g in patients with
the smallest infarcts (Figure 3). However, the relative re-
duction in infarct size over time (as a percent of the ini-
tial infarct size) was independent of initial infarct size
and was the same across the 3 tertiles (Figure 3 right
panel). The mean percent reduction in infarct mass
among the tertiles ranged from 28% to 31% from acute
necrosis to early scar and from 38% to 40% from acute
necrosis to late scar.
MVO was identified in 44% of the cohort (29 of 66) in
the setting of acute necrosis. Patients without MVO had
an average infarct size of 16 ± 13 g, and patients with
MVO had larger average infarct size of 35 ± 16 g
(p < 0.0001). The MVO patients had a greater absolute
reduction in infarct size of 9 ± 6 g over a year, but the
relative decrease in size was not statistically different
(p = 0.6) between patients with and without MVO.
Ventricular remodeling
LV remodeling, defined as an increase in EDVI of
greater than 20% following acute MI [16,17], was seen in
12 patients (18%) between acute necrosis and early scar
and 14 patients (21%) between acute necrosis and late
scar. For patients who developed adverse LV remodeling
by 3 months, the mean infarct size decreased from
34 ± 24 g to 22 ± 15 g (p = 0.007), and for patients with
remodeling at 14 months, the mean infarct size
decreased from 30 ± 19 g to 19 ± 15 g (p = 0.002). Al-
though patients with adverse remodeling had larger
infarcts, there was no statistical difference in infarct sizes
at any time point between patients with and without re-
modeling. Additionally, only 4 subjects with MVO had
adverse LV remodeling and 10 subjects with MVO had
no adverse LV remodeling (p = 0.2).
Discussion
Infarct resorption occurs at a steady pace following the
acute injury of an MI. In this study, we confirmed that
1) the percent reduction in infarct size is independent of
the initial infarct size, and 2) infarct resorption occurs
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Figure 1 Changes over time in infarct mass. Scatter plot showing the changes in absolute infarct mass over time (A) and the changes in
infarct size as a percent of left ventricular mass over time (B) for all patients.
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year.
Previous studies demonstrated that patients undergo-
ing LV remodeling have a poor prognosis, and the likeli-
hood of the heart undergoing adaptive adverse
remodeling is dependent on the size of the acute MI
[7,16,17]. Therefore, the goal of reperfusion therapies
lies primarily in limiting the amount of acutely infarcted
tissue. Little is known about the relation between the
adaptive changes that the LV undergoes and infarct heal-
ing, as the acutely necrotic tissue is reabsorbed and
replaced with a fibrotic collagenous scar. This process of
remodeling is important clinically as more patients sur-
vive the acute MI, as many will later present with heart
failure [18].
Reimer and Jennings alluded to the reduction of over-
all infarct size between acute and chronic studies in
dogs. Earlier studies found that infarct size in dog mod-
els increased over the first 48 hours and then remained
unchanged in size out to 10 days [19,20], but this data
was published prior to wide use of inversion recovery
technique for infarct analysis. Fieno and colleagues later
described the natural history of healed reperfused and
nonreperfused infarcts using more modern CMR techni-
ques in dogs and found that infarct size decreased by
11 ± 8%, 33 ± 2%, and 46 ± 3% at 1 month, respectively,
for arteries occluded for 45 minutes, for 90 minutes, and
permanently. At 2 months, infarct size continued to de-
cline by 10 ± 6%, 32 ± 2%, and 22 ± 3%, respectively, of
the acute infarct size [10].Studies in humans have reported similar findings.
Ingkanisorn and colleagues demonstrated that the per-
cent of infarcted myocardium decreased significantly in
20 patients, from 16 ± 12% to 11 ± 9% of the LV myocar-
dium (reduction of 31%) over a median of 5 months
after acute MI [9]. Lund and colleagues reported a de-
crease from 19 ± 10% to 14 ± 8% of LV myocardium (re-
duction of 26%) at 8 months post-MI [4]. In keeping
with this prior experience, in the current study, we
observed a reduction in infarct size from 21 ± 13% to
16 ± 11% of LV mass (reduction of 24%) over a mean 4-
month time period.
With a greater number of patients, compared to the
previous reports, and with a greater variability of initial
infarct size, we demonstrated that the percent reduction
of infarct size is independent of initial infarct size even
though absolute reductions in infarct size are greater in
patients with larger infarcts. Other investigators have
noted that reductions in infarct size are largest in
patients with CMR evidence for MVO [21]. However, we
note that MVO tends to occur in subjects with larger in-
farct sizes.
The reports of changing infarct size over time has led
some investigators to conclude that infarct size mea-
sured during the sub-acute phase overestimates the true
infarct size [8,22]. Reimer and Jennings initially described a
24% “overestimation” of infarct size due to edema, but the
edematous region was confined within the necrotic zone
[8]. Aletras and colleagues [22] demonstrated differences
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Figure 3 Absolute versus relative changes in infarct size. Bar graphs sh
percent of the initial infarct mass (right) at the 3 time points among patien
analysis with post hoc Bonferroni correction reveal that patients with the la
compared to the other two tertiles. However, the relative change in infarct
Figure 2 Infarct healing over time. Bar graph showing infarct
mass (A) and infarct size (as percent of left ventricular mass, B) at
acute necrosis, early scar, and late scar in patients subgrouped into
tertiles of initial infarct size. Data are mean± SD. Asterisks indicate
p< 0.002 by paired t-test compared to previous time point, which is
statistically significant after Bonferroni correction for 22 comparisons.
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weighted edematous region matched the area at risk
determined by microspheres, and infarct area was sig-
nificantly smaller than the area at risk. However, if over-
estimation of initial infarct size due to edema or partial
volume effects accounted for all of the apparent reduc-
tions in infarct size over time, reduction in the area
LGE in the chronic phase should not occur. As demon-
strated by Dall’Armellina, edema is unlikely to be
present 6 months after AMI [23]. Our data indicate that
incremental infarct healing occurs in the chronic phase,
between 4 months and 14 months following acute MI.
The rapid reduction in infarct size over the first sev-
eral months after MI has important implications regard-
ing the clinical measurement of infarct size by CMR, as
this is usually not performed immediately after MI (as in
our research protocol). If infarct size measurement is
performed within 3–4 months of an acute MI, the tim-
ing between the acute event and evaluation of scar is
paramount. It is likely, although currently unproven, that
infarct size decreases on a day-to-day or week-to-week
basis, and more research is necessary to accurately
characterize the minimum time frame during which
CMR can measure decreases in the extent of LGE. Previ-
ous studies with myocardial perfusion imaging using sin-
gle photon emission computed tomography (SPECT)
reported differences in infarct size between 3 days and
1 week after MI [24]. It was hypothesized that the perfu-
sion defects seen acutely were overestimations due to
alterations in microvascular perfusion. SPECT imaging
performed between 5 and 9 days after the acute event
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in perfusion sizes by SPECT imaging more likely repre-
sent a true reduction in infarct size.
Our data also indicate that infarct size continues to
decrease slightly (3%) but significantly during the
chronic phase between 4 and 14 months. Although the
magnitude of this change may appear modest, emerging
evidence suggests this finding may carry important prog-
nostic and pathophysiologic implications. Kwong et al.
assessed the prognostic value of infarct size by CMR in
195 patients with a clinical history of prior MI [25]. Al-
though only 22% of patients had demonstrable scar by
CMR, the presence and extent of LGE was significantly
related to subsequent mortality. For every 1% increment
in infarct size, there was an associated 10% increase in
cardiac mortality (HR 1.10, [1.06 – 1.15], p < 0.0001).
Roes et al. assessed the prognostic value of infarct size
in 231 patients with evidence of LGE by CMR [26]. In-
farct size was estimated using a semiquantitative scar
score. In that study, a 1-point increment in scar score
(equivalent to 1.5% of the left ventricle) was associated
with a greater than 6-fold increase in all-cause mortality
(HR 6.2 [1.7-23], p < 0.006), even after adjusting for 8
other clinical predictors including age, LVEF, and LV
volumes.
Conclusions
Reduction in infarct size is a dynamic and continuous
process that extends well beyond the initial phase of in-
farct healing. Absolute changes in infarct size and mass
beyond 4 months are small but statistically significant
and may be clinically important. As more investigators
use CMR imaging to monitor infarct size, a greater
understanding of infarct healing will be achieved. Our
data indicate that management decisions based on in-
farct size and interventions to reduce infarct size must
take into consideration the time frame of measurement.
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